1 / 10

Jeffrey Altenburg, Ph.D. Methodist Research Institute Phone: (317) 962-2750

Mutations in the C-terminal BBXB domains of CXCL12 γ restore chemotactic activity and enhance anti-HIV effects. Jeffrey Altenburg, Ph.D. Methodist Research Institute Phone: (317) 962-2750 Email: jaltenbu@clarian.org. Introduction.

gwidon
Télécharger la présentation

Jeffrey Altenburg, Ph.D. Methodist Research Institute Phone: (317) 962-2750

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Mutations in the C-terminal BBXB domains of CXCL12γ restore chemotactic activity and enhance anti-HIV effects Jeffrey Altenburg, Ph.D. Methodist Research Institute Phone: (317) 962-2750 Email: jaltenbu@clarian.org

  2. Introduction • CXCL12γ is an isotype of CXCL12 that contains four overlapping heparin sulfate binding sequences (BBXB) in the carboxy terminus • CXCL12γ is the strongest inhibitor of X4-tropic HIV entry and the weakest inducer of chemotaxis • We mutated the BBXB domains to determine if they are the reason for the changes in function

  3. CXCL12γ has the most potent anti-HIV activity and least potent chemotaxis activity Chemotaxis X4-mediated fusion Altenburg JD et al. J Virol. 2007 Aug;81(15):8140-8.

  4. Mutations of the BBXB domains were expressed and purified from bacteria

  5. Mutation of the C-terminal BBXB domains restores chemotaxis activity and enhances HIV inhibition Chemotaxis X4-mediated fusion

  6. Binding to both CXCR4 and heparin sulfate is increased with CXCL12γ CXCR4 binding – flow method CXCR4 binding – I-125 method HSPG binding

  7. CXCR4 internalization is increased upon treatment with CXCL12γ

  8. Inhibition pattern is identical in HSPG- cells compared to HSPG+ cells Sog9 LM(tk-) HSPG HSPG

  9. Conclusions • CXCL12γ binds with greater affinity to CXCR4 and heparin sulfate than CXCL12α • CXCL12γ induces a greater amount of CXCR4 internalization than CXCL12α = Our proposed mechanism • Increased binding to heparin sulfate may be the mechanism behind chemotaxis reduction for CXCL12γ but is not the mechanism behind its increased anti-HIV activity • Optimal CXCL12 antiviral activity might require a human-specific factor

  10. Acknowledgements IUSM Lab: Ghalib Alkhatib, PhD Q Jin, MD; X Lu, MD; L Agrawal, PhD; IV Nicolescu, MD; Z VanHorne-Ali, K Grunden, J Gil MRI Lab: Rafat Siddiqui, PhD K Harvey; C Antalis, PhD; S Natarjan, PhD; A Hudson; J Korte; C Walker

More Related